Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 11032 results:
[ Συντάκτης(Desc)] Τίτλος Τύπος Έτος
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
P
Patoulias, D., & Papadopoulos C. (2020).  Meta-analysis Evaluating the Risk of Atrial Fibrillation With Newer Antidiabetics Across the Cardiovascular and Renal Outcome Trials.
Patoulias, D., & Papadopoulos C. (2020).  Sodium-glucose co-transporter-2 inhibitors, cardiovascular outcomes and the impact of gender: Class effect or statistical play of chance?.
Patoulias, D., & Papadopoulos C. (2020).  Updated Meta-Analysis of Trials Assessing the Cardiovascular Efficacy of Sodium-Glucose Co-Transporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists in Black Patients.
Patoulias, D., Papadopoulos C., Stavropoulos K., Zografou I., Doumas M., & Karagiannis A. (2020).  Prognostic value of arterial stiffness measurements in cardiovascular disease, diabetes, and its complications: The potential role of sodium-glucose co-transporter-2 inhibitors.. J Clin Hypertens (Greenwich).
Patoulias, D., & Papadopoulos C. (2020).  Postdischarge antidiabetic treatment in patients with type 2 diabetes and acute coronary syndrome: Time for a change?.
Patoulias, D., & Papadopoulos C. (2020).  Acute heart failure, type 2 diabetes and loop diuretic use: any adjunct role for sodium-glucose cotransporter-2 inhibitors?.
Patoulias, D., & Papadopoulos C. (2020).  Meta-Analysis Assessing the Effects of Allopurinol on Left Ventricular Mass and Other Indices of Left Ventricular Remodeling as Evaluated by Cardiac Magnetic Resonance Imaging..
Patoulias, D., & Papadopoulos C. (2020).  Glucagon-like peptide-1 receptor agonists or sodium–glucose cotransporter-2 inhibitors as add-on therapy for patients with type 2 diabetes? A systematic review and meta-analysis of surrogate metabolic endpoints.
Patoulias, D., & Papadopoulos C. (2020).  Updated Meta-analysis Assessing the Effect of Sodium-Glucose Co-transporter-2 Inhibitors on Surrogate End points in Patients With Heart Failure With Reduced Ejection Fraction.
Patoulias, D., Katsimardou A., Kalogirou M-S., Karagiannis A., & Doumas M. (2019).  Is there any place for sodium-glucose co-transporter-2 inhibitors in post-liver transplantation patients?. Dig Liver Dis.
Patoulias, D., Stavropoulos K., Imprialos K., Athyros V., Doumas M., & Karagiannis A. (2019).  Pharmacological Management of Cardiac Disease in Patients with Type 2 Diabetes: Insights into Clinical Practice. Curr Vasc Pharmacol.
Patoulias, D., Manafis A., Mitas C., Avranas K., Lales G., Zografou I., et al. (2018).  Sodium-glucose Cotransporter 2 Inhibitors and the Risk of Diabetic Ketoacidosis; from Pathophysiology to Clinical Practice.. Cardiovasc Hematol Disord Drug Targets. 18(2), 139-146.
Patoulias, D., & Papadopoulos C. (2020).  Postdischarge antidiabetic treatment in patients with type 2 diabetes and acute coronary syndrome: Time for a change?.
Patoulias, D., & Papadopoulos C. (2020).  Meta-Analysis Assessing the Cardiovascular Efficacy of Sodium-Glucose Co-Transporter-2 Inhibitors According to Baseline Treatment of Interest.
Patoulias, D., & Papadopoulos C. (2020).  Time to assess the effects of sodium–glucose co-transporter-2 inhibitors on the ‘forgotten' right ventricle?.
Patoulias, D., Doumas M., Kotsis V., Stavropoulos K., Imprialos K., Zografou I., et al. (2019).  Liraglutide as adjunct to insulin treatment in patients with type 1 diabetes: A systematic review and meta-analysis.. Curr Diabetes Rev.
Patriki, D., & Giannopoulos A. A. (2018).  Cardiovascular risk prediction models with myocardial perfusion imaging in chronic kidney disease: ACCESSing digits or focusing on the patient?. J Nucl Cardiol.
Patsali, M. E., Mousa D-P. V., Papadopoulou E. V. K., Papadopoulou K. K. K., Kaparounaki C. K., Diakogiannis I., et al. (2020).  University students' changes in mental health status and determinants of behavior during the COVID-19 lockdown in Greece.. Psychiatry Res. 292, 113298.
Patsas, A., Tsiaousis P., Papaziogas B., Koutelidakis I., Goula C., & Atmatzidis K. (2010).  Repair of a giant inguinoscrotal hernia.. Hernia. 14(3), 305-7.
Patsatsi, A., Vavilis D., Tsikeloudi M., Kalabalikis D., & Sotiriadis D. (2012).  Refractory pemphigoid gestationis postpartum.. Acta Obstet Gynecol Scand. 91(5), 636-7.
Patsatsi, A., Meltzanidou P., Katafigiotis S., Sotiriadis D., Schmidt E., & Lambropoulos A. (2017).  Chronic bullous disease of childhood with IgG reactivity to p200 antigen.. Int J Dermatol. 56(7), 773-775.
Patsatsi, A., Kyriakou A., Karavasilis V., Tsatsou F., Lazaridis G., Kalabalikis D., et al. (2014).  Acquired ichthyosis triggered by an osseous hemangiopericytoma: a case report and review of the literature.. Case Rep Dermatol. 6(1), 10-5.
Patsatsi, A., Lazaridou E., Fotiadou C., Kyriakou A., & Sotiriadis D. (2014).  Large cell acanthoma: a debate throughout the decades.. Dermatol Pract Concept. 4(1), 43-5.
Patsatsi, A., Kyriakou A., Meltzanidou P., Trigoni A., Lamprou F., Kokolios M., et al. (2018).  Βullous pemphigoid in patients with DPP-4 inhibitors at the onset of disease: does this differ from common bullous pemphigoid?. Eur J Dermatol. 28(5), 711-713.
Patsatsi, A., Sotiriou E., Devliotou-Panagiotidou D., & Sotiriadis D. (2009).  Pemphigus vulgaris affecting 19 nails.. Clin Exp Dermatol. 34(2), 202-5.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές